REQUEST A DEMO
Total
USD $0.00
Search more companies

Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) (Egypt)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ibnsina Pharma S.A.E. Profile Updated: March 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) is based in Egypt. The head office is in Cairo. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 02, 2026. It currently has a total number of 9,731 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 37.17% in 2025. A growth of 26.44% was recorded in its total assets. The net profit margin of Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) increased by 0.14% in 2025.

Headquarters
Bulding No. 234, 2Nd District, 5Th Settlement, New Cairo
Cairo; Greater Cairo;

Contact Details: Purchase the Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) report to view the information.

Website: http://www.ibnsina-pharma.com

Basic Information
Total Employees:
Purchase the Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) report to view the information.
Outstanding Shares:
Purchase the Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) report to view the information.
Financial Auditors:
Purchase the Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) report to view the information.
Incorporation Date:
April 02, 2026
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
13.99%
Purchase this report to view the information.
6%
Purchase this report to view the information.
5.08%
Subsidiaries
A.I.M For Investing And Medical Consulting
99.99%
Ramb For Logistics Services Company
99.99%
Dg Three Sixty For Programming
78.99%
Company Performance
Financial values in the chart are available after Ibnsina Pharma S.A.E. (ابن سينا فارما المساهمة (القاهرة)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
37.17%
Total Operating Revenue
37.19%
Operating Profit
56.03%
EBITDA
51.37%
Net Profit/Loss for the Period
54.9%
Total Assets
26.44%
Total Equity
37.06%
Operating Profit Margin
0.62%
Net Profit Margin
0.14%
Return on Equity (ROE)
3.94%
Debt / Equity
-48107%
Quick Ratio
21.91%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?